Driving performance of stable outpatients with depression undergoing real‐world treatment

This is the authors' abstract. We don't add key points for this paper.

We conclude that partly remitted depressive patients under steady-state pharmacologic treatment do not differ from healthy controls with respect to driving performance, which seems to be more affected by psychosocial functioning than by pharmacologic agents. This, however, should be investigated systematically in an off/on study.